Reactions 1704, p282 - 2 Jun 2018 Radiation recall dermatitis: case report A 70-year-old man developed radiation recall dermatitis secondary to nivolumab therapy [dosage and route not stated]. The man was diagnosed with metastatic non-small cell lung and was started on nivolumab (PD-1 inhibitor). He also had liver metastases, which was treated with course of radiotherapy to both the liver and upper lobe of right lung 6 months before. However, within 2 weeks of the start of the treatment with nivolumab, he developed two distinct rashes, both erythematous and scaly in appearance across both his abdomen and upper chest. The rashes were comparable to radiotherapy sites. The diagnosis was persistent with radiation recall dermatitis [outcome not stated]. Author comment: "This is the ﬁrst recorded incidence of a radiation recall dermatitis associated with a PD-1 inhibitor." Mazzoni D, et al. Radiation recall dermatitis secondary to PD-1 Inhibitor. A new adverse reaction. Australasian Journal of Dermatology 59 (Suppl. 1): 86, May 2018. Available from: URL: http://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323585 » Editorial comment: 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera